Search results

  • CSV Spreadsheet
  • RSS Feed
(1 - 20 of 21)
Artificial immune cell, AI-cell, a new tool to predict interferon production by peripheral blood monocytes in response to nucleic acid nanoparticles
Biomotors, viral assembly, and RNA nanobiotechnology : current achievements and future directions
Biomotors, viral assembly, and rna nanobiotechnology: current achievements and future directions
Break to build : isothermal assembly of nucleic acid nanoparticles (NANPs) via enzymatic degradation
Broccoli fluorets : split aptamers as a user-friendly fluorescent toolkit for dynamic RNA nanotechnology
Change in lipofectamine carrier as a tool to fine-tune immunostimulation of nucleic acid nanoparticles
Characterization of cationic bolaamphiphile vesicles for sirna delivery into tumors and brain
DNA-templated fluorescent silver nanoclusters inhibit bacterial growth while being non-toxic to mammalian cells
Demonstrating the synthesis and antibacterial properties of nanostructured silver
Exosome mediated delivery of functional nucleic acid nanoparticles (NANPs)
Expanding structural space for immunomodulatory nucleic acid nanoparticles (NANPs) via spatial arrangement of their therapeutic moieties
Functionally-interdependent shape-switching nanoparticles with controllable properties
Functionally-interdependent shape-switching nanoparticles with controllable properties
Induction of cytokines by nucleic acid nanoparticles (NANPs) depends on the type of delivery carrier
Retinoic acid inducible gene-I mediated detection of bacterial nucleic acids in human microglial cells
Special issue nanotechnology to overcome the world's most critical health issues: liposomes and beyond-a themed issue dedicated to Professor Yechezkel Barenholz
Structure and composition define immunorecognition of nucleic acid nanoparticles
The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification
The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification
The recognition of and reactions to nucleic acid nanoparticles by human immune cells